Trials / Terminated
TerminatedNCT00737594
Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
A Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Sucampo Pharma Americas, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to determine the efficacy and safety of cobiprostone (at two dose levels) as compared to placebo for lowering portal hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Matching placebo capsules for oral administration |
| DRUG | Cobiprostone | Cobiprostone capsules for oral administration |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-02-01
- Completion
- 2009-03-01
- First posted
- 2008-08-19
- Last updated
- 2019-11-18
- Results posted
- 2016-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00737594. Inclusion in this directory is not an endorsement.